-
Chairman’s Address to Annual General Meeting
November 30, 2006
-
Heads of Agreement with Recovery Clinics Pty Ltd
November 30, 2006
Analytica is pleased to announce that a non-binding Heads of Agreement with Recovery Clinics Pty Ltd has been entered into after Analytica made an offer to acquire all of the issued capital of Recovery Clinics.
-
Heads of Agreement with InJet Digital Aerosols Limited
November 29, 2006
Analytica is pleased to announce that it has entered into a non-binding Heads of Agreement with InJet Digital Aerosols Limited (IDAL). Analytica and IDAL will now progress due diligence and negotiations with a view to Analytica potentially acquiring all of the issued capital of IDAL.
-
September quarter 2006 cash flow- Appendix 4c.
October 27, 2006
-
2006 Annual Report
October 27, 2006
-
Notice of Annual General Meeting
October 27, 2006
The Analytica Limited Annual General Meeting will be held at 9.00am on Thursday 30 November at the BTP Technology and Conference Centre, 1 Clunies Ross Court, Eight Mile Plains, Queensland 4113. The Notice of Meeting, Explanatory Memorandum and 2006 Annual Report were dispatched to shareholders today.
-
Appointment and Resignation of Company Secretary
October 19, 2006
Analytica is pleased to announce the appointment of Mr Ben Graham as Company Secretary effective today. Mr Bryan Dulhunty has tendered his resignation as Company Secretary to enable him to spend additional time in his role as Executive Chairman of Psiron Limited.
-
TGA approval to sell Lingyang Joint Venture products granted
October 18, 2006
Analytica Ltd (ASX:ALT) has been granted approval by the Therapeutic Goods Administration to have a number of products included on the Australian Register of Therapeutic Goods. Inclusion on the ARTG permits Analytica, as the regulatory sponsor, to advertise and sell these products in the Australian market.
-
Appendix 4E - Preliminary Final Report
September 08, 2006
-
TGA submission for regulatory approval
August 30, 2006
Analytica Ltd (ASX:ALT) has lodged formal submissions with the Therapeutic Goods Administration (TGA) for regulatory approval of a number of products manufactured by its Joint Venture partner Zhejiang Lingyang Medical Apparatus Co.
-
Quarterly cash flow – Appendix 4C
July 31, 2006
-
Change of Share Register Address Notification
June 19, 2006
Please be advised that effective start of business Monday, 19 June 2006, the Brisbane street address and facsimile number of our share registrar are changing.
-
Application for patent for a manually operated safety needle
June 05, 2006
Analytica today announced that it has recently applied for a patent (AU 2006902128) for a manually operated safety needle.
-
Signing of Joint Venture Patent License Agreement
May 17, 2006
Analytica Limited today announced the signing of a patent license agreement with its newly formed joint venture company in Hong Kong.
-
Signing of Joint Venture Agreement
May 16, 2006
Analytica Limited today announced the formation of a joint venture company in Hong Kong with Zhejiang Lingyang Medical Apparatus Company of Linhai, China and J and J Stamina company of Taiwan.
-
Commitments Test Entity - Third Quarter Report
April 27, 2006
March Quarter cash flow - Appendix 4c
-
Resignation of Chairman Mr. Stephen Jones and Appendix 3Z
March 28, 2006
Mr Stephen Jones has advised the Company that he will today resign as Chairman and Director of the Company.
-
Appendix 4D - Half Yearly Report and Half Yearly Accounts
March 10, 2006
-
Company response to ASX query on December quarter appendix 4c
February 06, 2006
-
Appendix 4C - Quarterly report for entities admitted on the basis of commitments
January 30, 2006
-
Form 604 Notice of Change of Interests of Substantial Holder
January 23, 2006
-
Organisational Restructure
January 20, 2006
Mr Stephen Goodall, the CEO and Managing Director of Analytica Limited, has resigned today from the board and his executive position due to health issues.
